Arbutus Biopharma Corp (NASDAQ:ABUS)

4.04
Delayed Data
As of Jan 22
 +0.08 / +2.02%
Today’s Change
0.88
Today|||52-Week Range
9.02
+13.80%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Arbutus Biopharma Corp have a median target of 7.50, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +85.64% increase from the last price of 4.04.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Arbutus Biopharma Corp. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$2.1M
Reporting Date
Mar 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.67%
 
 
 
 
 
 
Growthannually 66.09%
 
 
 
 
 
 

Sales

Growthquarterly 39.29%
 
 
 
 
 
 
Growthannually 8.86%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.